Meobentine sulphate (bis[N-4-methoxybenzyl-N'N"-dimethylguanidine]sulphate): a new antidysrhythmic agent.
D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000378:metabolism / Q000494:pharmacology*; D001341:Autonomic Nervous System / Q000187:drug effects; D002319:Cardiovascular System / Q000187:drug effects; D004285:Dogs; D006146:Guanidines / Q000494:pharmacology*; D006168:Guinea Pigs; D066298:In Vitro Techniques; D008760:Methylguanidine / Q000031:analogs & derivatives / Q000494:pharmacology*; D051379:Mice; D009206:Myocardium / Q000378:metabolism; D010042:Ouabain / Q000037:antagonists & inhibitors; D011817:Rabbits; D051381:Rats; D014693:Ventricular Fibrillation / Q000188:drug therapy
D000889:Anti-Arrhythmia Agents; D006146:Guanidines; D010042:Ouabain; D008760:Methylguanidine; C032896:meobentine